In vitro anti-herpes simplex virus activity of 1,2,4,6-tetra-O-galloyl- β-D-glucose from Phyllanthus emblica L. (Euphorbiaceae)

Phytotherapy Research

Volumn 25, Issue 7, 2011, Pages 975-982

  Xiang, Yangfei ^a   Pei, Ying ^a   Qu, Chang ^a   Lai, Zhicai ^a   Ren, Zhe ^a   Yang, Ke ^a   Xiong, Sheng ^a   Zhang, Yingjun ^b   Yang, Chongren ^b   Wang, Dong ^b   Liu, Qing ^b   Kitazato, Kaio ^c   Wang, Yifei ^a  

^a JINAN UNIVERSITY   (China)

^b KUNMING INSTITUTE OF BOTANY   (China)

^c NAGASAKI UNIVERSITY   (Japan)

Author keywords

1,2,4,6 Tetra O galloyl D glucose; Anti herpes simplex virus activity; HSV; Phyllanthus emblica L. (Euphorbiaceae); Polyphenol

Indexed keywords

1,2,4,6 TETRA O GALLOYL BETA DEXTRO GLUCOSE; ACICLOVIR; ANTIVIRUS AGENT; EMBLICA OFFICINALIS EXTRACT; GLYCOPROTEIN E1; UNCLASSIFIED DRUG; VIRUS DNA; VIRUS RNA;

ANIMAL CELL; ANTIVIRAL ACTIVITY; ARTICLE; CONTROLLED STUDY; CYTOTOXICITY TEST; DNA REPLICATION; DRUG EFFECT; DRUG ISOLATION; DRUG MECHANISM; DRUG SCREENING; DRUG STRUCTURE; EMBLICA OFFICINALIS; HERPES SIMPLEX; HERPES SIMPLEX VIRUS 1; HERPES SIMPLEX VIRUS 2; IN VITRO STUDY; NONHUMAN; PROTEIN SYNTHESIS INHIBITION; RNA SYNTHESIS; VIROGENESIS; VIRUS ATTACHMENT; VIRUS ENTRY; VIRUS GENE; VIRUS PARTICLE; VIRUS STRAIN;

ANIMALS; ANTIVIRAL AGENTS; CERCOPITHECUS AETHIOPS; DNA, VIRAL; GALLIC ACID; HERPESVIRUS 1, HUMAN; HERPESVIRUS 2, HUMAN; MONOSACCHARIDES; PHYLLANTHUS EMBLICA; VERO CELLS; VIRAL PROTEINS; VIRUS REPLICATION;

EUPHORBIACEAE; HUMAN HERPESVIRUS 1; PHYLLANTHUS EMBLICA; SIMPLEXVIRUS; TETRA;

EID: 84860390197     PISSN: 0951418X     EISSN: 10991573     Source Type: Journal    
DOI: 10.1002/ptr.3368     Document Type: Article

References (24)

1. Burns WH, Saral R, Santos GW et al. 1982. Isolation and characterization of resistant herpes simplex virus after acyclovir therapy. Lancet 1:421-423. (Pubitemid 12163009)
2. Cheng HY, Lin TC, Yang CM, Wang KC, Lin LT, Lin CC. 2004. Putranjivain A from Euphorbia jolkini inhibits both virus entry and late stage replication of herpes simplex virus type 2 in vitro. J Antimicrob Chemother 53:577-583.
3. Cheng HY, Lin TC, Yang CM, Shieh DE, Lin CC. 2005. In vitro anti-HSV-2 activity and mechanism of action of proanthocyanidin A-1 from Vaccinium vitis-idaea. J Sci Food Agric 85:10-15.
4. Coen DM, Schaffer PA. 2003. Antiherpesvirus drugs: a promising spectrum of new drugs and drug targets. Nat Rev Drug Discov 2:278-288. (Pubitemid 37361686)
5. Corey L, Adams HG, Brown ZA, Holmes KK. 1983. Genital herpes simplex virus infections: clinical manifestations, course, and complications. Ann Intern Med 98:958-972. (Pubitemid 13053413)
6. Crumpacker CS, Schnipper LE, Marlowe SI, Kowalsky PN, Hershey BJ, Levin MJ. 1982. Resistance to antiviral drugs of herpes simplex virus isolated from a patient treated with acyclovir. N Engl J Med 306:343-346. (Pubitemid 12169116)
7. Isaacs CE, Wen GY, Xu W et al. 2008. Epigallocatechin gallate inactivates clinical isolates of herpes simplex virus. Antimicrob Agents Chemother 52:962-970. (Pubitemid 351359065)
8. Kalinyak JE, Fleagle G, Docherty JJ. 1977. Incidence and distribution of herpes simplex virus types 1 and 2 from genital lesions in college women. J Med Virol 1:175-181.
9. Khan MT, Ather A, Thompson KD, Gambari R. 2005. Extracts and molecules from medicinal plants against herpes simplex viruses. Antivir Res 67:107-119. (Pubitemid 41112627)
10. Kurokawa M, Hozumi T, Basnet P et al. 1998. Purification and characterization of eugeniin as an anti-herpesvirus compound from Geum japonicum and Syzygium aromaticum. J Pharmacol Exp Ther 284:728-735. (Pubitemid 28086665)
11. Kurokawa M, Hozumi T, Tsurita M, Kadota S, Namba T, Shiraki K. 2001. Biological characterization of eugeniin as an anti-herpes simplex virus type 1 compound in vitro and in vivo. J Pharmacol Exp Ther 297:372-379. (Pubitemid 32242598)
12. Leung DT, Sacks SL. 2004. Docosanol: a topical antiviral for herpes labialis. Expert Opin Pharmacother 5:2567-2571. (Pubitemid 39646518)
13. Lin LC, Kuo YC, Chou CJ. 2000. Anti-herpes simplex virus type-1 flavonoids and a new flavanone from the root of Limonium sinense. Planta Med 66:333-336.
14. Lyu SY, Rhim JY, Park WB. 2005. Antiherpetic activities of flavonoids against herpes simplex virus type 1 (HSV-1) and type 2 (HSV-2) in vitro. Arch Pharm Res 28:1293-1301.
15. Nitta K, Shiota H, Nito T, Mimura Y. 1994. Sensitivities to other antiviral drugs and thymidine kinase activity of aciclovirresistant herpes simplex virus type 1. Nippon Ganka Gakkai Zassh 98:513-519. (Pubitemid 24201429)
16. Russell WC. 1962. A sensitive and precise plaque assay for herpes virus. Nature 195:1028-1029.
17. Sibrack CD, Gutman LT, Wilfert CM et al. 1982. Pathogenicity of acyclovir resistant herpes simplex virus type 1 from an immunodeficient child. J Infect Dis 146:673-682. (Pubitemid 13250821)
18. Song JM, Lee KH, Seong BL. 2005. Antiviral effect of catechins in green tea on influenza virus. Antiviral Res 68:66-74.
19. Su CT, Hsu JT, Hsieh HP et al. 2008. Anti-HSV activity of digitoxin and its possible mechanisms. Antiviral Res 79:62-70.
20. Uozaki M, Yamasaki H, Katsuyama Y, Hiquchi M, Hiquti T, Koyama AH. 2007. Antiviral effect of octyl gallate against DNA and RNA viruses. Antiviral Res 73:85-91. (Pubitemid 46135766)
21. Whitley RJ, Kimberlin DW, Roizman B. 1998. Herpes simplex viruses. Clin Infect Dis 26:541-553.
22. Xia Q, Xiao PG, Wang LW, Kong J. 1997. Ethnopharmacology of Phyllanthus emblica L. Zhongguo Zhongyao Zazhi 22:515-518.
23. Yang CM, Cheng HY, Lin TC, Chiang LC, Lin CC. 2007. The in vitro activity of geraniin and 1, 3, 4, 6-tetra-O-galloyl-β-D-glucose isolated from Phyllanthus urinaria against herpes simplex virus type 1 and type 2 infection. J Ethnopharmacol 110:555-558.
24. Zhang YJ, Abe T, Tanaka T, Yang CR, Kouno I. 2002. Two new acylated flavanone glycosides from the leaves and branches of Phyllanthus emblica. Chem Pharm Bull 50:841-843. (Pubitemid 41694907)